There were no associations between other types of antidepressant classes and breast cancer risk
Tell your doctor if you are breast-feeding
Tamoxifen is a SERM
Background: Classical hormone replacement therapy for hot flashes is contraindicated in breast cancer especially in endocrine responsive disease
Venlafaxine and clonidine are effective treatments in the management of hot flashes in patients with breast cancer
Women with a history of breast cancer also appear to prefer the antidepressant Effexor ® (venlafaxine) over the anti-seizure drug Neurontin ®
Around 57 Australians are diagnosed with breast cancer every day, with more than 2
All trials were multi-centered and conducted in the United States
Venlafaxine (Effexor), the therapy of choice for these symptoms, has numerous adverse effects
Effexor, also known as venlafaxine, is an antidepressant medication
In assessing risks among the five most commonly used antidepressants, we detected no association with fluoxetine, sertraline, venlafaxine, or buproprion hydrochloride
Purpose Nonhormonal pharmacologic interventions are recommended for the treatment of hot flashes in breast cancer survivors
This was an 8-week, multicenter, randomized, single-blind, active-controlled trial conducted at a psychiatric hospital (Beijing Anding Hospital) and a general hospital (Beijing Chaoyang Hospital) between
We undertook a double-blind, placebo-controlled, randomised trial to assess the efficacy of venlafaxine in women with a history of breast cancer or reluctance to take hormonal treatment because of fear of breast cancer
Introduction
We hypothesized that venlafaxine, a selective-norepinephrine reuptake inhibitor drug, was
The phase IV clinical study analyzes which people take Effexor and have Breast cancer
As regards SNRIs use for HFs in breast cancer survivors ( Table 2 ), most studies focussed on venlafaxine [ 24, 25 ]
Patients and methods: In a double-blind, randomized phase III study, breast cancer patients suffering from hot flashes at least twice a day, who were not taking any medication against hypertension and
Methods: In a double-blind, cross-over study, 60 breast cancer patients experiencing HF were randomized to 8 weeks venlafaxine followed by 2 weeks wash-out, and 8 weeks clonidine or vice versa